SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 26.34 |
| Enterprise Value ($M) | 27.06 |
| Book Value ($M) | 4.98 |
| Book Value / Share | 2.42 |
| Price / Book | 5.29 |
| NCAV ($M) | -2.61 |
| NCAV / Share | -1.27 |
| Price / NCAV | -10.09 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.72 |
| Return on Assets (ROA) | -1.44 |
| Return on Equity (ROE) | -2.69 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.40 |
| Current Ratio | 0.40 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1.36 |
| Assets | 8.96 |
| Liabilities | 3.97 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 4.99 | -46.15 | |
| 13G | Geller Avi |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 37,350 | 131,103 | 28.49 | |
| 14,790 | 91,158 | 16.22 | |
| 17,618 | 47,076 | 37.42 | |
| 20,861 | 127,948 | 16.30 | |
| 30,884 | 105,809 | 29.19 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CNSP – CNS Pharmaceuticals, Inc. | CNTX – Context Therapeutics Inc. |
| COCP – Cocrystal Pharma, Inc. | CORT – Corcept Therapeutics Incorporated |
| COYA – Coya Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io